EIF3A and cancer: The selective enhancement of translation initiation on cancer-associated transcripts by the EIF3A HLH motif highlights a new mode of eIF3 translation regulation and identifies a well-defined, discrete structural motif [14] that could be targeted for future drug development efforts.